Press Releases
July 30, 2026
Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded
July 24, 2026
Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews
Upcoming Events
Past Events
30Jul
2026
Second quarter 2026 results
Second quarter 2026 results were reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation was followed by a Q&A session.
Quarterly results
23Apr
2026
First quarter 2026 results
Q1 2026 results were reviewed by management during a live audio webcast with the financial community on April 23, 2026. The presentation was followed by a Q&A session.
Quarterly results
29Jan
2026
Fourth quarter & full year 2025 results
Fourth quarter and full year 2025 results were reviewed by management during a live audio webcast with the financial community on January 29, 2026. The presentation was followed by a Q&A session.
Quarterly results